The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Supply Chain Strategies & Solutions Article
Download Article
Guides/Reports
In 2016, AHRMM convened the AHRMM CQO Task Force, a group of healthcare leaders collaborating to identify real world examples of supply chain
Case Studies
AHRMM is building a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
White Papers
This paper explores nine different methods of replenishing a hospital storage area and compares and contrasts the steps nursing must progress thr
White Papers
The Purpose of this white paper is to prepare Supply Chain professionals to better understand how to support navigating some of the risks and oppor
Supply Chain Strategies & Solutions Article
Medical device manufacturers have been working hard to comply with the new Unique Device Identification (UDI) regulations from the FDA that are aim